Search and analyze individual stocks with comprehensive metrics
Ambuja Cements Limited
Fundamental Score
Ambuja Cements Limited Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AMBUJACEM across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (17.87%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 33.35 vs Industry: 46.73)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Strong Revenue Growth (22.60%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (29.53x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (67.57%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Strong Institutional Confidence (FII+DII: 25.92%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
3 factors identified
Below-Average Return on Equity (8.73%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Negative Free Cash Flow (₹-1880.66 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Cement & Cement Products sector...
Financial Statements
Comprehensive financial data for Ambuja Cements Limited
About AMBUJACEM
Company Details
Market Information
Performance
AMBUJACEM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of AMBUJACEM?
AMBUJACEM is currently trading at ₹566.75 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of AMBUJACEM shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of AMBUJACEM and what does it mean?
AMBUJACEM has a P/E ratio of 33.35x compared to the industry average of 46.73x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹33 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is AMBUJACEM performing according to Bull Run's analysis?
AMBUJACEM has a Bull Run fundamental score of 53.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 8.73%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does AMBUJACEM belong to?
AMBUJACEM operates in the Cement & Cement Products industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Ambuja Cements Limited. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for AMBUJACEM?
AMBUJACEM has an ROE of 8.73%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Ambuja Cements Limited generates profits from shareholders' equity. An ROE of 9% means the company generates ₹9 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is AMBUJACEM's debt-to-equity ratio and what does it indicate?
AMBUJACEM has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk. This means the company has ₹1 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.
What is AMBUJACEM's dividend yield and is it a good dividend stock?
AMBUJACEM offers a dividend yield of 0.34%, which means you receive ₹0.34 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has AMBUJACEM grown over the past 5 years?
AMBUJACEM has achieved 5-year growth rates of: Sales Growth 5.27%, Profit Growth 14.63%, and EPS Growth 9.79%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in AMBUJACEM and why does it matter?
Promoters hold 67.57% of AMBUJACEM shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does AMBUJACEM compare with its industry peers?
AMBUJACEM trades at P/E 33.35x vs industry average 46.73x, with ROE of 8.73% and ROCE of 10.50%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether AMBUJACEM is outperforming its competitive set in profitability, growth, and valuation metrics.
What is AMBUJACEM's market capitalization and what category does it fall into?
AMBUJACEM has a market capitalization of ₹144057 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for AMBUJACEM?
Key ratios for AMBUJACEM: ROE 8.73% (Needs improvement), ROCE 10.50%, P/E 33.35x, Debt-to-Equity 0.01, Interest Coverage 29.53x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is AMBUJACEM stock and what is its beta?
AMBUJACEM has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for AMBUJACEM?
AMBUJACEM has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹566.75, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in AMBUJACEM?
Key risks for AMBUJACEM include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.01), and operational challenges. The stock has a Fundamental Score of 53.5/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Cement & Cement Products include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is AMBUJACEM's operating profit margin and how has it trended?
AMBUJACEM has a 5-year average Operating Profit Margin (OPM) of 17.87%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. This strong margin indicates competitive advantages and operational leverage. Compare with industry peers to understand relative performance.
How is AMBUJACEM's quarterly performance in terms of sales and profit growth?
AMBUJACEM's recent quarterly performance shows YoY Sales Growth of 22.60% and YoY Profit Growth of 19.44%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in AMBUJACEM?
AMBUJACEM has FII holding of 7.43% and DII holding of 18.49%, totaling 25.92% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.